Coface SA stock forecast
Coface SA (65C) Stock Forecast & Price Target
65C Analyst Ratings
65C Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Berenberg Bank | €22.50→€21 | buy | 29.79%Upside | Reiterated | 07/31/26 | |||
| Baptiste de Leudeville | Kepler Capital | €17 | buy | 5.07%Upside | Reiterated | 04/23/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| BuyReiterated€22.50→€21 | 07/31/26 | 29.79%Upside | |||
| Baptiste de LeudevilleKepler Capital | BuyReiterated€17 | 04/23/26 | 5.07%Upside |
Best Analysts Covering Coface SA
Copying Baptiste de Leudeville's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.63% per trade.
Copying Baptiste de Leudeville's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +2.13% per trade.
Copying Baptiste de Leudeville's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +5.29% per trade.
65C Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 0 | 0 |
In the current month, 65C has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 65C average Analyst price target in the past 3 months is ―.
65C Financial Forecast
65C Earnings Forecast
Next quarter’s earnings estimate for 65C is EUR 0.32 with a range of ― to ―. The previous quarter’s EPS was EUR 0.32. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
65C Sales Forecast
Next quarter’s sales forecast for 65C is EUR 489.46M with a range of ― to ―. The previous quarter’s sales results were EUR 489.46M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

